Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2002 1
2003 5
2004 5
2005 1
2006 1
2007 4
2008 2
2010 3
2011 3
2012 3
2013 2
2014 5
2015 2
2016 4
2017 3
2018 11
2019 11
2020 15
2021 12
2022 15
2023 11
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Chang YH, Hajek J, Symeonides SN, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Gurney H, Chevreau C, Melichar B, Kopyltsov E, Alva A, Burke JM, Doshi G, Topart D, Oudard S, Hammers H, Kitamura H, Bedke J, Perini RF, Zhang P, Imai K, Willemann-Rogerio J, Quinn DI, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2021 Aug 19;385(8):683-694. doi: 10.1056/NEJMoa2106391. N Engl J Med. 2021. PMID: 34407342 Free article. Clinical Trial.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.
From Pac-Man to UltraMan.
Graham JD, Grissom CK. Graham JD, et al. Crit Care Med. 2023 Mar 1;51(3):415-418. doi: 10.1097/CCM.0000000000005777. Epub 2023 Feb 21. Crit Care Med. 2023. PMID: 36809263 No abstract available.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
Choueiri TK, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Chang YH, Lee JL, Sarwar N, Haas NB, Gurney H, Sawrycki P, Mahave M, Gross-Goupil M, Zhang T, Burke JM, Doshi G, Melichar B, Kopyltsov E, Alva A, Oudard S, Topart D, Hammers H, Kitamura H, McDermott DF, Silva A, Winquist E, Cornell J, Elfiky A, Burgents JE, Perini RF, Powles T; KEYNOTE-564 Investigators. Choueiri TK, et al. N Engl J Med. 2024 Apr 18;390(15):1359-1371. doi: 10.1056/NEJMoa2312695. N Engl J Med. 2024. PMID: 38631003 Clinical Trial.
Anchoring to a Diagnosis?
Aberegg SK, Graham J. Aberegg SK, et al. Among authors: graham j. JAMA Intern Med. 2023 Dec 1;183(12):1410. doi: 10.1001/jamainternmed.2023.5342. JAMA Intern Med. 2023. PMID: 37843839 No abstract available.
Personalized Management of Advanced Kidney Cancer.
Graham J, Heng DYC, Brugarolas J, Vaishampayan U. Graham J, et al. Am Soc Clin Oncol Educ Book. 2018 May 23;38:330-341. doi: 10.1200/EDBK_201215. Am Soc Clin Oncol Educ Book. 2018. PMID: 30231375 Free PMC article. Review.
Tuna comparative physiology.
Graham JB, Dickson KA. Graham JB, et al. J Exp Biol. 2004 Nov;207(Pt 23):4015-24. doi: 10.1242/jeb.01267. J Exp Biol. 2004. PMID: 15498947 Review.
Adjuvant therapy in renal cell carcinoma.
Massari F, Di Nunno V, Ciccarese C, Graham J, Porta C, Comito F, Cubelli M, Iacovelli R, Heng DYC. Massari F, et al. Among authors: graham j. Cancer Treat Rev. 2017 Nov;60:152-157. doi: 10.1016/j.ctrv.2017.09.004. Epub 2017 Sep 23. Cancer Treat Rev. 2017. PMID: 28992528 Review.
Advances in navigating to the nodule and targeting.
Graham J, Basist M, Frye L, Agrawal A, Nasim F. Graham J, et al. Curr Opin Pulm Med. 2024 Jan 1;30(1):9-16. doi: 10.1097/MCP.0000000000001021. Epub 2023 Nov 6. Curr Opin Pulm Med. 2024. PMID: 37930633 Review.
113 results